Our latest research and evaluations is published regularly in:
- 13 November 2017
Optimising treatment of osteoporosis
Osteoporosis is a common condition, especially among older Australians. Find out more about best practice treatment of osteoporosis.
- 31 October 2017
Combined oral contraceptive pills: supporting an informed choice
A woman’s choice of contraception will be based on many factors, including efficacy, potential side effects, non-contraceptive benefits, cost and personal preference. Find out more about how to help patients make informed choices about contraception.
- 12 October 2017
Over-the-counter codeine: hospitalisation costs revealed
Codeine misuse is a real problem. A new study has evaluated hospitalisation costs due to over-the-counter codeine misuse in a 593-bed Australian public hospital over a 5-year period. Find out more.
- Medicinewise News
- 11 October 2017
Osteoarthritis: an opportunity to promote weight loss with patients
Weight loss is core treatment for osteoarthritis, but can be hard to raise with patients. Find out how two clinicians tackle this topic.
- 9 October 2017
Can co-enzyme Q10 supplementation prevent or treat statin-associated muscle symptoms?
Co-enzyme Q10 is an antioxidant that some have hypothesised might be implicated in statin-associated muscle symptoms. Review the evidence.
- 9 October 2017
Paracetamol/ibuprofen combinations for acute pain
Paracetamol/ibuprofen combinations may be an alternative to codeine-based analgesics for short-term management of pain. Find out more.
- 21 September 2017
PPI use and risk of death – cause for concern?
PPI use was recently reported to increase risk of death. The results were significant and the methodology robust, The relevance to clinical practice is worthy of review.
- 28 June 2017
Just because symptoms can last a long time doesn’t mean children need antibiotics
Children's coughs and colds can be worrying. Find out how long these conditions last and why antibiotics won't help.
Contact our media team
If you are a journalist seeking comment on a story or more information on any of our programs or campaigns please contact the NPS MedicineWise media team
on 02 8217 8667.
For urgent media requests outside of office hours, please call 0419 618 365. If your request is not urgent you can also email an enquiry.
Publications & Programs
Australian Prescriber is an independent peer-reviewed journal that provides critical commentary on drugs and therapeutics for health professionals.
Peak stories have included the top 10 most expensive drugs, eradication of Hepatitis C, drug seeking behaviours in people and more.
RADAR provides health professionals with timely information on new drugs, medical tests and changes to listings on the Pharmaceutical Benefits Scheme and Medicare Benefits Schedule.
Peak stories have included warfarin, campaigns urging doctors to seeing health reps, and treating Hepatitis C.